Indivior PLC at Morgan Stanley Global Healthcare Conference (Virtual) Transcript
Good morning, and good afternoon, everyone. Thank you for joining this session at the Morgan Stanley Global Healthcare Conference. My name is Thibault Boutherin. I'm part of pharmaceuticals equity research team based in London. Before we start, I need to refer to important disclosures. (technical difficulty) as Morgan Stanley research. Would you like to start with some introductory comments on the current situation and the outlook for Indivior?
Thanks, Thibault and thanks for having us here today. And how poignant that this is national recovery month here in the U.S. for us to get together and talk about Indivior. I think Indivior is at a great spot with regards to its development and its future, just the strategic sort of options we have in front of us.
We've come out of material overhangs on the business in a very good spot. And for us, the way forward is extremely clear. We basically have a 4-pronged strategy as we move
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
